2024-10-17

Novavax shares plunge as company says FDA put hold on two shots

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Wednesday said the Food and Drug Administration has put a hold on its application for a combination shot targeting Covid and…

Read More

2024-09-28

FDA approves Bristol Myers Squibb’s schizophrenia drug

Bristol Myers Squibb’s Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol Myers Squibb‘s highly anticipated schizophrenia drug Cobenfy, the first novel type of treatment for the debilitating, chronic mental disorder in more than seven decades.  Schizophrenia affects how a person thinks, feels and behaves, and can cause paranoia, delusions, hallucinations, and changes…

Read More